The Global Erythropoietin (EPO) Market Report by The Business Research Company covers erythropoietin (EPO) market drivers and restraints, erythropoietin (EPO) market size, major players, and the impact of COVID-19 on the erythropoietin (EPO) market.

The erythropoietin (EPO) market consists of sales of erythropoietin drugs by entities (organizations, sole traders, and partnerships) that manufacture erythropoietin biosimilars. Erythropoietin is a hormone produced by kidneys and plays a vital role in the production of red blood cells, which carry oxygen from the lungs to the rest of the body. Lack of sufficient erythropoietin results in low red blood cells, which may lead to anemia. EPO drugs are used for treatment for anemia, kidney disorders, cancer, and other conditions.

The rising incidence of chronic kidney diseases is anticipated to propel the demand for the erythropoietin market over the approaching years. The global erythropoietin (EPO) market is expected to grow from $0.96 billion in 2020 to $1.1 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The EPO market is expected to reach $3.11 billion in 2025 at a CAGR of 30%.

Request A Sample For The Global Erythropoietin (EPO) Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

Some erythropoietin (EPO) market trends include mergers and acquisitions among companies. In August 2018, STADA Arzneimittel AG, a Germany-based pharmaceutical company, acquired majority stakes (51.34%) in Bioceuticals Arzneimittel AG for an undisclosed amount.

Global erythropoietin (EPO) market segments include:

1) By Product: Epoetin-Alfa, Epoetin-Beta, Darbepoetin-Alfa, Others.

2) By Application: Cancer, Hematology, Renal Diseases, Neurology, Others.

3) By Drug Class: Biologics, Biosimilar.

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth And Change To 2030 At:
https://www.thebusinessresearchcompany.com/report/erythropoietin-epo-global-market-report-2020-30-covid-19-growth-and-change

The Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides erythropoietin (EPO) market overviews, analyzes and forecasts market size, share, erythropoietin (EPO) market players, erythropoietin (EPO) market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.

The erythropoietin (EPO) market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More:

Read Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth And Change To 2030 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Market Players Covered: Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, LG Life Sciences Ltd.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.

Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Erythropoietin (EPO) Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.

Opportunities For Companies In The Erythropoietin (EPO) Sector: The report reveals where the global industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Here is a list of reports from The Business Research Company similar to the Erythropoietin (EPO) Global Market Report 2021:

Hematology Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Biosimilar Therapeutic Peptides Global Market Report 2021: COVID-19 Growth And Change To 2030

Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030